Annexin 1 (named p35, lipocortin I or calpactin II), initially describ
ed as a glucocorticoid induced protein, belongs to a new characterized
family of intracellular proteins. In the skin, the role of annexins h
as still not been elucidated. In a previous study, we reported the loc
alization of annexin 1 in both freshly isolated human epidermal cells
and in cultured keratinocytes using immunofluorescence, FACS analysis
and immunoblotting techniques. The protein was characterized by Wester
n blot and immunoprecipitation as a 35 kDa protein. Results from in vi
vo studies confirmed the presence of annexin 1 in basal and suprabasal
layers of normal human skin with modified reactivity patterns in hype
rproliferative lesions. In the present study, the role of glucocortico
ids in annexin 1 regulation was investigated in epidermal cells by Wes
tern blot and immunoprecipation assays. In contrast to other studies,
we found that glucocorticoid treatment of epidermal cells led to a dec
rease in annexin 1 content in the cytoplasm and the membranes of cells
. As annexin 1 was not detected in the nucleus of cells, we conclude t
hat there was a down regulation of annexin 1 after glucocorticoid trea
tments rather than a translocation of the protein to the nucleus. Desp
ite the absence of the signal peptide sequence necessary for protein s
ecretion, annexin 1 was released in the keratinocyte culture medium. W
e found that the protein was secreted only in low Ca2+ medium (0.15 mM
), this process required an active metabolism.